Skip to main content
OpenTrials

Clinical trial condition

Urogenital Neoplasms

Explore clinical trials studying Urogenital Neoplasms. Study availability and eligibility vary by location and protocol.

12,025 public trials 2,564 recruiting studies
Refine in advanced search Browse all conditions

Urogenital Neoplasms trial results

Recruiting

Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer

NCT05009082

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Klinikum St. Marien Amberg Amberg, Germany
  • Klinikum Augsburg Augsburg, Germany
  • Hochtaunus-Kliniken Bad Homburg, Germany
  • Helios Klinikum Berlin-Buch Berlin, Germany
View all 65 locations
View Trial Details
Recruiting

A Study of NX-1607 in Adults With Advanced Malignancies

NCT05107674

Conditions
Adenoma, Adnexal Diseases, Breast Diseases, +75 more
Locations
  • City of Hope Duarte, California, United States
  • University of Southern California Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Colorado School of Medicine Aurora, Colorado, United States
View all 17 locations
View Trial Details
Recruiting

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

NCT04510597

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 387 locations
View Trial Details
Recruiting

Prehabilitation to Patients With Prostate Cancer

NCT07162987

Conditions
Disease, Genital Diseases, Genital Diseases, Male, +11 more
Locations
  • Esbjerg Hospital Esbjerg, Region Syddanmark, Denmark
  • REHPA, the Danish Knowledge Centre for Rehabilitation and Palliative Care Nyborg, Region Syddanmark, Denmark
  • Vejle Hospital Vejle, Region Syddanmark, Denmark
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

NCT06682793

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • UCSD Moores Cancer Center La Jolla, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
View Trial Details
Recruiting

A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

NCT05932862

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +26 more
Locations
  • Exelixis Clinical Site #12 Fountain Valley, California, United States
  • Exelixis Clinical Site #15 Jacksonville, Florida, United States
  • Exelixis Clinical Site #8 Orlando, Florida, United States
  • Exelixis Clinical Site #16 Tampa, Florida, United States
View all 16 locations
View Trial Details

Related conditions